Cargando…
PB2079: INTERIM REPORT OF BENDAMUSTINE PLUS RITUXIMAB AS FIRST-LINE INDUCTION THERAPY WITH OR WITHOUT LENALIDOMIDE MAINTENANCE THERAPY IN CHINESE PATIENTS WITH INHL OR EMCL: A MULTI-CENTER PROSPECTIVE TRIAL
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429533/ http://dx.doi.org/10.1097/01.HS9.0000851148.10454.66 |
| _version_ | 1784779474328354816 |
|---|---|
| author | Wang, H. He, Q. Zhao, R. Xie, L. Ma, J. Liu, C. Lu, K. Wei, H. Liu, D. Xing, L. Deng, X. Sun, Z. Chu, X. Gao, N. Zhong, Y. Sun, Y. Zhang, H. Zhang, H. Xu, W. Li, Z. |
| author_facet | Wang, H. He, Q. Zhao, R. Xie, L. Ma, J. Liu, C. Lu, K. Wei, H. Liu, D. Xing, L. Deng, X. Sun, Z. Chu, X. Gao, N. Zhong, Y. Sun, Y. Zhang, H. Zhang, H. Xu, W. Li, Z. |
| author_sort | Wang, H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429533 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94295332022-08-31 PB2079: INTERIM REPORT OF BENDAMUSTINE PLUS RITUXIMAB AS FIRST-LINE INDUCTION THERAPY WITH OR WITHOUT LENALIDOMIDE MAINTENANCE THERAPY IN CHINESE PATIENTS WITH INHL OR EMCL: A MULTI-CENTER PROSPECTIVE TRIAL Wang, H. He, Q. Zhao, R. Xie, L. Ma, J. Liu, C. Lu, K. Wei, H. Liu, D. Xing, L. Deng, X. Sun, Z. Chu, X. Gao, N. Zhong, Y. Sun, Y. Zhang, H. Zhang, H. Xu, W. Li, Z. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429533/ http://dx.doi.org/10.1097/01.HS9.0000851148.10454.66 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Wang, H. He, Q. Zhao, R. Xie, L. Ma, J. Liu, C. Lu, K. Wei, H. Liu, D. Xing, L. Deng, X. Sun, Z. Chu, X. Gao, N. Zhong, Y. Sun, Y. Zhang, H. Zhang, H. Xu, W. Li, Z. PB2079: INTERIM REPORT OF BENDAMUSTINE PLUS RITUXIMAB AS FIRST-LINE INDUCTION THERAPY WITH OR WITHOUT LENALIDOMIDE MAINTENANCE THERAPY IN CHINESE PATIENTS WITH INHL OR EMCL: A MULTI-CENTER PROSPECTIVE TRIAL |
| title | PB2079: INTERIM REPORT OF BENDAMUSTINE PLUS RITUXIMAB AS FIRST-LINE INDUCTION THERAPY WITH OR WITHOUT LENALIDOMIDE MAINTENANCE THERAPY IN CHINESE PATIENTS WITH INHL OR EMCL: A MULTI-CENTER PROSPECTIVE TRIAL |
| title_full | PB2079: INTERIM REPORT OF BENDAMUSTINE PLUS RITUXIMAB AS FIRST-LINE INDUCTION THERAPY WITH OR WITHOUT LENALIDOMIDE MAINTENANCE THERAPY IN CHINESE PATIENTS WITH INHL OR EMCL: A MULTI-CENTER PROSPECTIVE TRIAL |
| title_fullStr | PB2079: INTERIM REPORT OF BENDAMUSTINE PLUS RITUXIMAB AS FIRST-LINE INDUCTION THERAPY WITH OR WITHOUT LENALIDOMIDE MAINTENANCE THERAPY IN CHINESE PATIENTS WITH INHL OR EMCL: A MULTI-CENTER PROSPECTIVE TRIAL |
| title_full_unstemmed | PB2079: INTERIM REPORT OF BENDAMUSTINE PLUS RITUXIMAB AS FIRST-LINE INDUCTION THERAPY WITH OR WITHOUT LENALIDOMIDE MAINTENANCE THERAPY IN CHINESE PATIENTS WITH INHL OR EMCL: A MULTI-CENTER PROSPECTIVE TRIAL |
| title_short | PB2079: INTERIM REPORT OF BENDAMUSTINE PLUS RITUXIMAB AS FIRST-LINE INDUCTION THERAPY WITH OR WITHOUT LENALIDOMIDE MAINTENANCE THERAPY IN CHINESE PATIENTS WITH INHL OR EMCL: A MULTI-CENTER PROSPECTIVE TRIAL |
| title_sort | pb2079: interim report of bendamustine plus rituximab as first-line induction therapy with or without lenalidomide maintenance therapy in chinese patients with inhl or emcl: a multi-center prospective trial |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429533/ http://dx.doi.org/10.1097/01.HS9.0000851148.10454.66 |
| work_keys_str_mv | AT wangh pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT heq pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT zhaor pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT xiel pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT maj pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT liuc pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT luk pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT weih pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT liud pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT xingl pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT dengx pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT sunz pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT chux pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT gaon pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT zhongy pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT suny pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT zhangh pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT zhangh pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT xuw pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial AT liz pb2079interimreportofbendamustineplusrituximabasfirstlineinductiontherapywithorwithoutlenalidomidemaintenancetherapyinchinesepatientswithinhloremclamulticenterprospectivetrial |